Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Results of SAR in the AAP-BHAP class of NNRTIs published by Pharmacia & Upjohn

Sep. 22, 1999

Licensing opportunity from NIH: chimeric proteins for preventing, treating HIV infection

Sep. 22, 1999

Two new AIDS treatment options introduced in Germany

Sep. 21, 1999

Clinical trials to begin with Chiron anti-HIV compound

Sep. 20, 1999

Novel anti-HIV agents with 2-deoxystreptamine scaffold designed by Scriptgen

Sep. 20, 1999

Cell Genesys reacquires product rights for AIDS gene therapy

Sep. 17, 1999

Use of Chiron's IL-2 product for HIV therapy authorized in France

Sep. 15, 1999

Novel antiretroviral agents discovered at CNRS

Sep. 15, 1999

Hollis-Eden updates progress of HE-2000 clinical trials

Sep. 13, 1999

Important market launch for Ziagen

Sep. 10, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.